CL2015002153A1 - Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano - Google Patents

Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano

Info

Publication number
CL2015002153A1
CL2015002153A1 CL2015002153A CL2015002153A CL2015002153A1 CL 2015002153 A1 CL2015002153 A1 CL 2015002153A1 CL 2015002153 A CL2015002153 A CL 2015002153A CL 2015002153 A CL2015002153 A CL 2015002153A CL 2015002153 A1 CL2015002153 A1 CL 2015002153A1
Authority
CL
Chile
Prior art keywords
respiratory
characterize
severity
molecular markers
syncytial virus
Prior art date
Application number
CL2015002153A
Other languages
English (en)
Inventor
Parra Alexis Mikes Kalergis
Ramírez Susan Marcela Bueno
Navarrete José Pablo Bertrand
Remolcoi Margarita Kam-Lem Lay
Original Assignee
Pontificia Universidad Católica De Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Católica De Chile filed Critical Pontificia Universidad Católica De Chile
Priority to CL2015002153A priority Critical patent/CL2015002153A1/es
Publication of CL2015002153A1 publication Critical patent/CL2015002153A1/es
Priority to CA2994252A priority patent/CA2994252A1/en
Priority to EP16832386.3A priority patent/EP3329019B1/en
Priority to CN201680052892.7A priority patent/CN108368556B/zh
Priority to RU2018104707A priority patent/RU2707549C2/ru
Priority to ES16832386T priority patent/ES2783859T3/es
Priority to PT168323863T priority patent/PT3329019T/pt
Priority to PE2018000146A priority patent/PE20180577A1/es
Priority to BR112018002140-7A priority patent/BR112018002140B1/pt
Priority to US15/748,984 priority patent/US11085080B2/en
Priority to PCT/IB2016/054423 priority patent/WO2017021814A1/en
Priority to KR1020187005531A priority patent/KR102621463B1/ko
Priority to MX2018001373A priority patent/MX2018001373A/es
Priority to UY0001036819A priority patent/UY36819A/es
Priority to ARP160102327A priority patent/AR105542A1/es
Priority to ZA2018/00940A priority patent/ZA201800940B/en
Priority to CONC2018/0001917A priority patent/CO2018001917A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5403—IL-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5434—IL-12
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/54—Determining the risk of relapse

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

USO DE LOS MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR LA SEVERIDAD DE INFECCIONES RESPIRATORIAS POR VIRUS RESPIRATORIO SINCICIAL (VRS).
CL2015002153A 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano CL2015002153A1 (es)

Priority Applications (17)

Application Number Priority Date Filing Date Title
CL2015002153A CL2015002153A1 (es) 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano
MX2018001373A MX2018001373A (es) 2015-07-31 2016-07-25 Uso de los marcadores moleculares il-3, il-33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincitial y metapneumovirus humano.
PT168323863T PT3329019T (pt) 2015-07-31 2016-07-25 Utilização de il-3, il-33 e il-12p40 para caracterização de infeções respiratórias pelo vírus sincicial respiratório
BR112018002140-7A BR112018002140B1 (pt) 2015-07-31 2016-07-25 Uso de marcadores moleculares il-3, il-33 e il-12p40 para caracterizar as gravidades das infecções respiratórias por vírus respiratório sincitial e metapneumovírus humano
CN201680052892.7A CN108368556B (zh) 2015-07-31 2016-07-25 Il-3、il-33和il-12p40用于表征由合胞呼吸道病毒引起的呼吸系统感染的用途
RU2018104707A RU2707549C2 (ru) 2015-07-31 2016-07-25 ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА
ES16832386T ES2783859T3 (es) 2015-07-31 2016-07-25 Uso de IL-3, IL-33, e IL-12P40 para caracterización de las infecciones respiratorias por Virus Respiratorio Sincitial
CA2994252A CA2994252A1 (en) 2015-07-31 2016-07-25 Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus
PE2018000146A PE20180577A1 (es) 2015-07-31 2016-07-25 USO DE LOS MARCADORES MOLECULARES IL-3, IL-33 E IL-12p40 PARA CARACTERIZAR LA SEVERIDAD DE INFECCIONES RESPIRATORIAS POR VIRUS RESPIRATORIO SINCICIAL Y METAPNEUMOVIRUS HUMANO
EP16832386.3A EP3329019B1 (en) 2015-07-31 2016-07-25 Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus
US15/748,984 US11085080B2 (en) 2015-07-31 2016-07-25 Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
PCT/IB2016/054423 WO2017021814A1 (en) 2015-07-31 2016-07-25 Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus
KR1020187005531A KR102621463B1 (ko) 2015-07-31 2016-07-25 호흡기 세포융합 바이러스에 의한 호흡기 감염의 특성화를 위한 il-3, il-33 및 il-12p40의 용도
UY0001036819A UY36819A (es) 2015-07-31 2016-07-27 USO DE LOS MARCADORES MOLECULARES IL-3, IL-33 e IL-12p40 PARA CARACTERIZAR LA SEVERIDAD DE INFECCIONES RESPIRATORIAS POR VIRUS RESPIRATORIO SINCICIAL Y METAPNEUMOVIRUS HUMANO
ARP160102327A AR105542A1 (es) 2015-07-31 2016-07-29 USO DE LOS MARCADORES MOLECULARES IL-3, IL-33 E IL-12p40 PARA CARACTERIZAR LA SEVERIDAD DE INFECCIONES RESPIRATORIAS POR VIRUS RESPIRATORIO SINCICIAL Y METAPNEUMOVIRUS HUMANO
ZA2018/00940A ZA201800940B (en) 2015-07-31 2018-02-12 Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus
CONC2018/0001917A CO2018001917A2 (es) 2015-07-31 2018-02-22 Método de detección de virus causante de enfermedades respiratorias por virus respiratorio sincitial y metapneumovirus humano

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2015002153A CL2015002153A1 (es) 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano

Publications (1)

Publication Number Publication Date
CL2015002153A1 true CL2015002153A1 (es) 2016-01-29

Family

ID=56081023

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002153A CL2015002153A1 (es) 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano

Country Status (17)

Country Link
US (1) US11085080B2 (es)
EP (1) EP3329019B1 (es)
KR (1) KR102621463B1 (es)
CN (1) CN108368556B (es)
AR (1) AR105542A1 (es)
BR (1) BR112018002140B1 (es)
CA (1) CA2994252A1 (es)
CL (1) CL2015002153A1 (es)
CO (1) CO2018001917A2 (es)
ES (1) ES2783859T3 (es)
MX (1) MX2018001373A (es)
PE (1) PE20180577A1 (es)
PT (1) PT3329019T (es)
RU (1) RU2707549C2 (es)
UY (1) UY36819A (es)
WO (1) WO2017021814A1 (es)
ZA (1) ZA201800940B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201791029A1 (ru) 2014-11-10 2017-12-29 Дженентек, Инк. Антитела против интерлейкина-33 и их применение
US20160168640A1 (en) 2014-11-10 2016-06-16 Genentech, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
KR20220152262A (ko) 2020-03-13 2022-11-15 제넨테크, 인크. 항-인터루킨-33 항체 및 이의 용도
JP6960642B2 (ja) * 2020-04-16 2021-11-05 国立研究開発法人国立国際医療研究センター 呼吸器感染症の重症化の予測を補助する方法、バイオマーカーの測定値をモニタリングする方法、これらの方法に用いられる試薬キット、呼吸器感染症の重症化の予測を補助する装置およびコンピュータプログラム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110008329A1 (en) * 2007-06-26 2011-01-13 Medlmmune, Llc Methods of Treating RSV Infections And Related Conditions
KR101286463B1 (ko) * 2011-01-28 2013-07-16 환인제약 주식회사 천궁 추출물을 함유하는 호흡기 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
RU2018104707A (ru) 2019-08-28
CN108368556A (zh) 2018-08-03
BR112018002140B1 (pt) 2024-01-23
EP3329019B1 (en) 2020-01-01
MX2018001373A (es) 2018-06-15
CN108368556B (zh) 2021-06-22
UY36819A (es) 2017-01-31
WO2017021814A1 (en) 2017-02-09
KR102621463B1 (ko) 2024-01-04
CO2018001917A2 (es) 2018-05-10
KR20180028525A (ko) 2018-03-16
BR112018002140A2 (pt) 2018-09-11
EP3329019A4 (en) 2018-06-06
RU2018104707A3 (es) 2019-08-28
RU2707549C2 (ru) 2019-11-27
US11085080B2 (en) 2021-08-10
ZA201800940B (en) 2019-07-31
CA2994252A1 (en) 2017-02-09
PE20180577A1 (es) 2018-04-04
PT3329019T (pt) 2020-04-08
US20180327843A1 (en) 2018-11-15
AR105542A1 (es) 2017-10-11
EP3329019A1 (en) 2018-06-06
ES2783859T3 (es) 2020-09-18

Similar Documents

Publication Publication Date Title
CY1122695T1 (el) Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος
CL2016002679A1 (es) Métodos para mejorar o acelerar la recuperación física después la cirugía por fractura de cadera.
CL2016001120A1 (es) Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
CL2018000883A1 (es) Moduladores del receptor x farnesoide
CL2016002455A1 (es) Anticuerpos multiespecíficos.
MX2021002168A (es) Compuestos antivirales.
CR20160419A (es) Nuevos compuestos biciclicos
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
CL2017003107A1 (es) Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
BR112015029088A2 (pt) sistema de múltiplas bateladas para preparar uma solução de hidrogeno carbonato de cálcio, e, uso de uma solução de hidrogeno carbonato de cálcio
PH12015502146A1 (en) 4-amino-6-(4-substituted-phenyl)-picolinates and 6-amino-2-(4-substituted-phenyl)-pyrimidine-4-carboxylates and their use as herbicides
EA201591397A1 (ru) Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
BR112015032526A2 (pt) composições anticaspa e métodos de uso das mesmas
BR112015020838A2 (pt) processo para a preparação de poliamidas, poliamida e uso de uma poliamida.
CL2015002153A1 (es) Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano
DK2952523T3 (da) Trail-mutant, der er membran-penetrerende og peptid-lignende, fremgangsmåde til fremstilling af samme og anvendelse deraf
MX2018005785A (es) Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
BR112016018371A2 (pt) derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmo
CO2019011271A2 (es) Análogos de deutetrabenazina, su preparación y uso
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso